Barclays lowered the firm’s price target on Grifols to EUR 13 from EUR 18 and keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Grifols simplifies financial presentation, limits non-recurring items
- Grifols’ Procleix ArboPlex Assay receives CE Mark
- Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening
- Grifols says CNMV validates financial statements, indebtedness of Grifols
- Grifols sees addressing 2025 maturities ‘efficiently’ in first half of 2024
